 [
    {
        "id": 2305,
        "drug_name": "DARZALEX (Daratumumab) using ENHANZE",
        "clinical_trial_id": "NCT03201965",
        "has_trial_insight_page": 0,
        "indication": "Amyloidosis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-01-15",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/99620788-6002-4a0b-8f6f-bf20621822fc",
        "note": "FDA approval announced January 15, 2021.",
        "company_entity_id": 380,
        "company_ticker": "JNJ",
        "company_name": "Johnson & Johnson",
        "company_price": "162.7400",
        "company_change": 1.51,
        "company_percent_change": 0.94,
        "company_optionable": 1,
        "company_number_of_shares": 2408767228,
        "price_change_sparkline": [
            [
                157.701248890579,
                1706677200
            ],
            [
                157.165322682896,
                1706763600
            ],
            [
                155.428524787625,
                1706850000
            ],
            [
                154.6246354761,
                1707109200
            ],
            [
                156.867585900849,
                1707195600
            ],
            [
                156.788189425637,
                1707282000
            ],
            [
                155.220109040193,
                1707368400
            ],
            [
                155.577393178648,
                1707454800
            ],
            [
                156.659170153417,
                1707714000
            ],
            [
                155.289580956004,
                1707800400
            ],
            [
                154.565088119691,
                1707886800
            ],
            [
                156.728642069228,
                1707973200
            ],
            [
                156.55,
                1708059600
            ],
            [
                157.86,
                1708405200
            ],
            [
                158.68,
                1708491600
            ],
            [
                160.45,
                1708578000
            ],
            [
                161.84,
                1708664400
            ],
            [
                160.79,
                1708923600
            ],
            [
                160.98,
                1709010000
            ],
            [
                161.55,
                1709096400
            ],
            [
                161.38,
                1709182800
            ],
            [
                162.12,
                1709269200
            ],
            [
                159.84,
                1709528400
            ],
            [
                159.97,
                1709614800
            ],
            [
                159.34,
                1709701200
            ],
            [
                158.87,
                1709787600
            ],
            [
                159.52,
                1709874000
            ],
            [
                161.23,
                1710129600
            ],
            [
                162.74,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2305,
        "drug_name": "DARZALEX (Daratumumab) using ENHANZE",
        "clinical_trial_id": "NCT03201965",
        "has_trial_insight_page": 0,
        "indication": "Amyloidosis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-01-15",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/99620788-6002-4a0b-8f6f-bf20621822fc",
        "note": "FDA approval announced January 15, 2021.",
        "company_entity_id": 156,
        "company_ticker": "HALO",
        "company_name": "Halozyme Therapeutics Inc.",
        "company_price": "41.9500",
        "company_change": 0.75,
        "company_percent_change": 1.8199999999999998,
        "company_optionable": 1,
        "company_number_of_shares": 126824800,
        "price_change_sparkline": [
            [
                33.85,
                1706677200
            ],
            [
                34.26,
                1706763600
            ],
            [
                33.68,
                1706850000
            ],
            [
                33.68,
                1707109200
            ],
            [
                35.02,
                1707195600
            ],
            [
                35.31,
                1707282000
            ],
            [
                35.24,
                1707368400
            ],
            [
                35.49,
                1707454800
            ],
            [
                35.69,
                1707714000
            ],
            [
                34.64,
                1707800400
            ],
            [
                35.06,
                1707886800
            ],
            [
                35.91,
                1707973200
            ],
            [
                36.1,
                1708059600
            ],
            [
                36,
                1708405200
            ],
            [
                38.36,
                1708491600
            ],
            [
                39.72,
                1708578000
            ],
            [
                40.56,
                1708664400
            ],
            [
                39.67,
                1708923600
            ],
            [
                39.84,
                1709010000
            ],
            [
                39.69,
                1709096400
            ],
            [
                39.81,
                1709182800
            ],
            [
                41.11,
                1709269200
            ],
            [
                40.93,
                1709528400
            ],
            [
                41.41,
                1709614800
            ],
            [
                41.69,
                1709701200
            ],
            [
                41.71,
                1709787600
            ],
            [
                41.73,
                1709874000
            ],
            [
                41.2,
                1710129600
            ],
            [
                41.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2305,
        "drug_name": "DARZALEX (Daratumumab) using ENHANZE",
        "clinical_trial_id": "NCT03201965",
        "has_trial_insight_page": 0,
        "indication": "Amyloidosis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-01-15",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/99620788-6002-4a0b-8f6f-bf20621822fc",
        "note": "FDA approval announced January 15, 2021.",
        "company_entity_id": 684,
        "company_ticker": "GMAB",
        "company_name": "Genmab A\/S",
        "company_price": "31.4300",
        "company_change": -0.25,
        "company_percent_change": -0.79,
        "company_optionable": 1,
        "company_number_of_shares": 660745350,
        "price_change_sparkline": [
            [
                27.61,
                1706677200
            ],
            [
                28.17,
                1706763600
            ],
            [
                27.8,
                1706850000
            ],
            [
                27.57,
                1707109200
            ],
            [
                28.15,
                1707195600
            ],
            [
                27.97,
                1707282000
            ],
            [
                27.79,
                1707368400
            ],
            [
                27.84,
                1707454800
            ],
            [
                27.49,
                1707714000
            ],
            [
                26.43,
                1707800400
            ],
            [
                27.59,
                1707886800
            ],
            [
                28.23,
                1707973200
            ],
            [
                28.71,
                1708059600
            ],
            [
                28.95,
                1708405200
            ],
            [
                28.95,
                1708491600
            ],
            [
                29.11,
                1708578000
            ],
            [
                29.16,
                1708664400
            ],
            [
                29.4,
                1708923600
            ],
            [
                29.05,
                1709010000
            ],
            [
                27.67,
                1709096400
            ],
            [
                27.77,
                1709182800
            ],
            [
                29.29,
                1709269200
            ],
            [
                28.51,
                1709528400
            ],
            [
                28.75,
                1709614800
            ],
            [
                28.86,
                1709701200
            ],
            [
                29.41,
                1709787600
            ],
            [
                30.3,
                1709874000
            ],
            [
                31.68,
                1710129600
            ],
            [
                31.43,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5175,
        "drug_name": "VERQUVO (vericiguat)",
        "clinical_trial_id": "NCT02861534",
        "has_trial_insight_page": 0,
        "indication": "Heart Failure",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-01-20",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210120005289\/en\/",
        "note": "FDA approval announced January 20, 2021.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4497,
        "drug_name": "JULUCA (dolutegravir and rilpivirine)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "HIV",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-01-21",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210121005951\/en\/",
        "note": "FDA approval announced January 21, 2021.",
        "company_entity_id": 379,
        "company_ticker": "GSK",
        "company_name": "GSK plc American Depositary Shares (Each representing two)",
        "company_price": "43.2700",
        "company_change": 0.35,
        "company_percent_change": 0.82,
        "company_optionable": 1,
        "company_number_of_shares": 2058516719,
        "price_change_sparkline": [
            [
                39.0637603938206,
                1706677200
            ],
            [
                40.2424083367376,
                1706763600
            ],
            [
                40.3315497777986,
                1706850000
            ],
            [
                41.1734411655964,
                1707109200
            ],
            [
                41.3517240477183,
                1707195600
            ],
            [
                41.6191483709012,
                1707282000
            ],
            [
                41.4210562796546,
                1707368400
            ],
            [
                41.5101977207156,
                1707454800
            ],
            [
                40.67821093748,
                1707714000
            ],
            [
                40.9951582834745,
                1707800400
            ],
            [
                41.40124707053,
                1707886800
            ],
            [
                41.371533256843,
                1707973200
            ],
            [
                41.5399115344025,
                1708059600
            ],
            [
                41.6191483709012,
                1708405200
            ],
            [
                41.5399115344025,
                1708491600
            ],
            [
                42.16,
                1708578000
            ],
            [
                42.22,
                1708664400
            ],
            [
                42.34,
                1708923600
            ],
            [
                42.38,
                1709010000
            ],
            [
                42.34,
                1709096400
            ],
            [
                41.9,
                1709182800
            ],
            [
                42.03,
                1709269200
            ],
            [
                42.44,
                1709528400
            ],
            [
                42.6,
                1709614800
            ],
            [
                42.62,
                1709701200
            ],
            [
                43.58,
                1709787600
            ],
            [
                43.14,
                1709874000
            ],
            [
                42.92,
                1710129600
            ],
            [
                43.27,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4497,
        "drug_name": "JULUCA (dolutegravir and rilpivirine)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "HIV",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-01-21",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210121005951\/en\/",
        "note": "FDA approval announced January 21, 2021.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3380,
        "drug_name": "LUPKYNIS (Voclosporin)",
        "clinical_trial_id": "NCT03021499",
        "has_trial_insight_page": 0,
        "indication": "Lupus",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-01-22",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210122005501\/en\/",
        "note": "FDA Approval announced January 22, 2021.",
        "company_entity_id": 56,
        "company_ticker": "AUPH",
        "company_name": "Aurinia Pharmaceuticals Inc",
        "company_price": "5.2000",
        "company_change": -0.17000000000000004,
        "company_percent_change": -3.17,
        "company_optionable": 1,
        "company_number_of_shares": 144617762,
        "price_change_sparkline": [
            [
                7.54,
                1706677200
            ],
            [
                7.73,
                1706763600
            ],
            [
                7.68,
                1706850000
            ],
            [
                7.55,
                1707109200
            ],
            [
                7.93,
                1707195600
            ],
            [
                7.78,
                1707282000
            ],
            [
                7.91,
                1707368400
            ],
            [
                8.29,
                1707454800
            ],
            [
                8.32,
                1707714000
            ],
            [
                7.78,
                1707800400
            ],
            [
                7.97,
                1707886800
            ],
            [
                6.02,
                1707973200
            ],
            [
                5.85,
                1708059600
            ],
            [
                5.59,
                1708405200
            ],
            [
                5.74,
                1708491600
            ],
            [
                6,
                1708578000
            ],
            [
                5.95,
                1708664400
            ],
            [
                6,
                1708923600
            ],
            [
                6.02,
                1709010000
            ],
            [
                5.84,
                1709096400
            ],
            [
                5.72,
                1709182800
            ],
            [
                5.78,
                1709269200
            ],
            [
                5.76,
                1709528400
            ],
            [
                5.6,
                1709614800
            ],
            [
                5.52,
                1709701200
            ],
            [
                5.45,
                1709787600
            ],
            [
                5.43,
                1709874000
            ],
            [
                5.37,
                1710129600
            ],
            [
                5.2,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3490,
        "drug_name": "POSIMIR",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Post-operative pain relief",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-02",
        "link": "https:\/\/www.prnewswire.com\/news-releases\/durect-corporation-announces-us-fda-approval-of-posimir-for-post-surgical-pain-reduction-for-up-to-72-hours-following-arthroscopic-subacromial-decompression-301220159.html",
        "note": "FDA approval announced February 2, 2021.",
        "company_entity_id": 119,
        "company_ticker": "DRRX",
        "company_name": "DURECT Corporation",
        "company_price": "1.1500",
        "company_change": 0.14,
        "company_percent_change": 13.86,
        "company_optionable": 1,
        "company_number_of_shares": 29828891,
        "price_change_sparkline": [
            [
                0.8121,
                1706677200
            ],
            [
                0.85,
                1706763600
            ],
            [
                0.849,
                1706850000
            ],
            [
                0.7824,
                1707109200
            ],
            [
                0.7566,
                1707195600
            ],
            [
                0.706,
                1707282000
            ],
            [
                0.756,
                1707368400
            ],
            [
                0.77,
                1707454800
            ],
            [
                0.85,
                1707714000
            ],
            [
                0.84,
                1707800400
            ],
            [
                0.945,
                1707886800
            ],
            [
                1.06,
                1707973200
            ],
            [
                1.04,
                1708059600
            ],
            [
                0.9694,
                1708405200
            ],
            [
                0.8801,
                1708491600
            ],
            [
                0.962,
                1708578000
            ],
            [
                0.98,
                1708664400
            ],
            [
                0.9567,
                1708923600
            ],
            [
                0.9951,
                1709010000
            ],
            [
                0.98,
                1709096400
            ],
            [
                1,
                1709182800
            ],
            [
                0.9813,
                1709269200
            ],
            [
                1.02,
                1709528400
            ],
            [
                0.97,
                1709614800
            ],
            [
                0.9777,
                1709701200
            ],
            [
                0.98,
                1709787600
            ],
            [
                1.01,
                1709874000
            ],
            [
                1.01,
                1710129600
            ],
            [
                1.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7127,
        "drug_name": "NPLATE (Romiplostim)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Hematopoietic Syndrome of Acute Radiation Syndrome",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-02",
        "link": "https:\/\/investors.amgen.com\/news-releases\/news-release-details\/amgen-reports-fourth-quarter-and-full-year-2020-financial",
        "note": "FDA approval announced in earnings release - February 2, 2021.",
        "company_entity_id": 372,
        "company_ticker": "AMGN",
        "company_name": "Amgen Inc.",
        "company_price": "276.5400",
        "company_change": 1.18,
        "company_percent_change": 0.43,
        "company_optionable": 1,
        "company_number_of_shares": 535918901,
        "price_change_sparkline": [
            [
                311.832823699025,
                1706677200
            ],
            [
                322.053272003295,
                1706763600
            ],
            [
                320.693853151174,
                1706850000
            ],
            [
                319.483275779212,
                1707109200
            ],
            [
                313.62884422628,
                1707195600
            ],
            [
                293.584858231498,
                1707282000
            ],
            [
                292.572736166415,
                1707368400
            ],
            [
                288.871544693121,
                1707454800
            ],
            [
                292.155980021969,
                1707714000
            ],
            [
                288.236487711108,
                1707800400
            ],
            [
                287.829654332006,
                1707886800
            ],
            [
                289.07,
                1707973200
            ],
            [
                283.7,
                1708059600
            ],
            [
                283.51,
                1708405200
            ],
            [
                283.46,
                1708491600
            ],
            [
                285.18,
                1708578000
            ],
            [
                289.18,
                1708664400
            ],
            [
                286.37,
                1708923600
            ],
            [
                278.49,
                1709010000
            ],
            [
                277.46,
                1709096400
            ],
            [
                273.83,
                1709182800
            ],
            [
                280.33,
                1709269200
            ],
            [
                279.39,
                1709528400
            ],
            [
                276.65,
                1709614800
            ],
            [
                276.59,
                1709701200
            ],
            [
                272.86,
                1709787600
            ],
            [
                273.75,
                1709874000
            ],
            [
                275.36,
                1710129600
            ],
            [
                276.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3604,
        "drug_name": "BREYANZI (lisocabtagene maraleucel)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Relapsed or refractory (R\/R) large B-cell lymphoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-05",
        "link": "https:\/\/www.prnewswire.com\/news-releases\/fda-approves-new-treatment-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma-301223275.html",
        "note": "FDA approval announced February 5, 2021.",
        "company_entity_id": 376,
        "company_ticker": "BMY",
        "company_name": "Bristol-Myers Squibb Company",
        "company_price": "54.4000",
        "company_change": 0.04,
        "company_percent_change": 0.07,
        "company_optionable": 1,
        "company_number_of_shares": 2022193411,
        "price_change_sparkline": [
            [
                48.87,
                1706677200
            ],
            [
                48.67,
                1706763600
            ],
            [
                48.71,
                1706850000
            ],
            [
                47.98,
                1707109200
            ],
            [
                49.26,
                1707195600
            ],
            [
                48.64,
                1707282000
            ],
            [
                48.71,
                1707368400
            ],
            [
                49.81,
                1707454800
            ],
            [
                49.75,
                1707714000
            ],
            [
                48.71,
                1707800400
            ],
            [
                48.89,
                1707886800
            ],
            [
                49.44,
                1707973200
            ],
            [
                49.86,
                1708059600
            ],
            [
                49.86,
                1708405200
            ],
            [
                50.91,
                1708491600
            ],
            [
                51.33,
                1708578000
            ],
            [
                51.66,
                1708664400
            ],
            [
                50.52,
                1708923600
            ],
            [
                50.51,
                1709010000
            ],
            [
                50.92,
                1709096400
            ],
            [
                50.75,
                1709182800
            ],
            [
                50.89,
                1709269200
            ],
            [
                50.92,
                1709528400
            ],
            [
                51.82,
                1709614800
            ],
            [
                53.38,
                1709701200
            ],
            [
                53.28,
                1709787600
            ],
            [
                53.79,
                1709874000
            ],
            [
                54.36,
                1710129600
            ],
            [
                54.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6954,
        "drug_name": "UKONIQ (umbralisib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Marginal zone lymphoma (MZL)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-05",
        "link": "https:\/\/ir.tgtherapeutics.com\/news-releases\/news-release-details\/tg-therapeutics-announces-fda-accelerated-approval-ukoniqtm",
        "note": "FDA approval announced February 5, 2021.",
        "company_entity_id": 292,
        "company_ticker": "TGTX",
        "company_name": "TG Therapeutics Inc.",
        "company_price": "15.8400",
        "company_change": -0.53,
        "company_percent_change": -3.24,
        "company_optionable": 1,
        "company_number_of_shares": 154420772,
        "price_change_sparkline": [
            [
                16.24,
                1706677200
            ],
            [
                16.88,
                1706763600
            ],
            [
                16.46,
                1706850000
            ],
            [
                15.31,
                1707109200
            ],
            [
                15.35,
                1707195600
            ],
            [
                14.37,
                1707282000
            ],
            [
                14.64,
                1707368400
            ],
            [
                14.74,
                1707454800
            ],
            [
                15.18,
                1707714000
            ],
            [
                13.93,
                1707800400
            ],
            [
                14.19,
                1707886800
            ],
            [
                14.4,
                1707973200
            ],
            [
                13.83,
                1708059600
            ],
            [
                13.23,
                1708405200
            ],
            [
                13.02,
                1708491600
            ],
            [
                13.44,
                1708578000
            ],
            [
                13.32,
                1708664400
            ],
            [
                13.36,
                1708923600
            ],
            [
                13.91,
                1709010000
            ],
            [
                17.63,
                1709096400
            ],
            [
                17.22,
                1709182800
            ],
            [
                17.96,
                1709269200
            ],
            [
                17.87,
                1709528400
            ],
            [
                18.08,
                1709614800
            ],
            [
                18.23,
                1709701200
            ],
            [
                18,
                1709787600
            ],
            [
                16.78,
                1709874000
            ],
            [
                16.37,
                1710129600
            ],
            [
                15.84,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3271,
        "drug_name": "UKONIQ (umbralisib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Follicular lymphoma (FL)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-05",
        "link": "https:\/\/ir.tgtherapeutics.com\/news-releases\/news-release-details\/tg-therapeutics-announces-fda-accelerated-approval-ukoniqtm",
        "note": "FDA approval announced February 5, 2021.",
        "company_entity_id": 292,
        "company_ticker": "TGTX",
        "company_name": "TG Therapeutics Inc.",
        "company_price": "15.8400",
        "company_change": -0.53,
        "company_percent_change": -3.24,
        "company_optionable": 1,
        "company_number_of_shares": 154420772,
        "price_change_sparkline": [
            [
                16.24,
                1706677200
            ],
            [
                16.88,
                1706763600
            ],
            [
                16.46,
                1706850000
            ],
            [
                15.31,
                1707109200
            ],
            [
                15.35,
                1707195600
            ],
            [
                14.37,
                1707282000
            ],
            [
                14.64,
                1707368400
            ],
            [
                14.74,
                1707454800
            ],
            [
                15.18,
                1707714000
            ],
            [
                13.93,
                1707800400
            ],
            [
                14.19,
                1707886800
            ],
            [
                14.4,
                1707973200
            ],
            [
                13.83,
                1708059600
            ],
            [
                13.23,
                1708405200
            ],
            [
                13.02,
                1708491600
            ],
            [
                13.44,
                1708578000
            ],
            [
                13.32,
                1708664400
            ],
            [
                13.36,
                1708923600
            ],
            [
                13.91,
                1709010000
            ],
            [
                17.63,
                1709096400
            ],
            [
                17.22,
                1709182800
            ],
            [
                17.96,
                1709269200
            ],
            [
                17.87,
                1709528400
            ],
            [
                18.08,
                1709614800
            ],
            [
                18.23,
                1709701200
            ],
            [
                18,
                1709787600
            ],
            [
                16.78,
                1709874000
            ],
            [
                16.37,
                1710129600
            ],
            [
                15.84,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7143,
        "drug_name": "LIBTAYO (cemiplimab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Basal cell carcinoma (BCC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-09",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/db98b762-19b0-4303-9561-6bdb2e5b1b4b",
        "note": "FDA approval announced February 9, 2021.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7143,
        "drug_name": "LIBTAYO (cemiplimab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Basal cell carcinoma (BCC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-09",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/db98b762-19b0-4303-9561-6bdb2e5b1b4b",
        "note": "FDA approval announced February 9, 2021.",
        "company_entity_id": 389,
        "company_ticker": "SNY",
        "company_name": "Sanofi",
        "company_price": "48.4600",
        "company_change": 0.11,
        "company_percent_change": 0.23,
        "company_optionable": 1,
        "company_number_of_shares": 2529599938,
        "price_change_sparkline": [
            [
                49.9,
                1706677200
            ],
            [
                48.41,
                1706763600
            ],
            [
                47.23,
                1706850000
            ],
            [
                46.95,
                1707109200
            ],
            [
                47.06,
                1707195600
            ],
            [
                46.92,
                1707282000
            ],
            [
                46.56,
                1707368400
            ],
            [
                46.5,
                1707454800
            ],
            [
                46.34,
                1707714000
            ],
            [
                45.75,
                1707800400
            ],
            [
                45.8,
                1707886800
            ],
            [
                46.39,
                1707973200
            ],
            [
                46.18,
                1708059600
            ],
            [
                46.85,
                1708405200
            ],
            [
                47.92,
                1708491600
            ],
            [
                47.8,
                1708578000
            ],
            [
                48.77,
                1708664400
            ],
            [
                48.2,
                1708923600
            ],
            [
                48.21,
                1709010000
            ],
            [
                48,
                1709096400
            ],
            [
                47.85,
                1709182800
            ],
            [
                47.29,
                1709269200
            ],
            [
                47.15,
                1709528400
            ],
            [
                47.5,
                1709614800
            ],
            [
                47.68,
                1709701200
            ],
            [
                48.06,
                1709787600
            ],
            [
                48.25,
                1709874000
            ],
            [
                48.35,
                1710129600
            ],
            [
                48.46,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6758,
        "drug_name": "BOTOX",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Neurogenic Detrusor Overactivity",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-10",
        "link": "https:\/\/news.abbvie.com\/news\/press-releases\/botox-onabotulinumtoxina-receives-fda-approval-for-pediatric-detrusor-overactivity-associated-with-neurologic-condition.htm",
        "note": "FDA approval announced February 10, 2021.",
        "company_entity_id": 369,
        "company_ticker": "ABBV",
        "company_name": "AbbVie Inc.",
        "company_price": "180.9200",
        "company_change": 1.29,
        "company_percent_change": 0.72,
        "company_optionable": 1,
        "company_number_of_shares": 1766473359,
        "price_change_sparkline": [
            [
                164.4,
                1706677200
            ],
            [
                167.59,
                1706763600
            ],
            [
                168.67,
                1706850000
            ],
            [
                171.26,
                1707109200
            ],
            [
                173.29,
                1707195600
            ],
            [
                175.01,
                1707282000
            ],
            [
                174.79,
                1707368400
            ],
            [
                174.08,
                1707454800
            ],
            [
                173.07,
                1707714000
            ],
            [
                173.29,
                1707800400
            ],
            [
                174.42,
                1707886800
            ],
            [
                176.59,
                1707973200
            ],
            [
                177.49,
                1708059600
            ],
            [
                175.75,
                1708405200
            ],
            [
                175.14,
                1708491600
            ],
            [
                176.75,
                1708578000
            ],
            [
                178.09,
                1708664400
            ],
            [
                178.81,
                1708923600
            ],
            [
                178.99,
                1709010000
            ],
            [
                178,
                1709096400
            ],
            [
                176.05,
                1709182800
            ],
            [
                178.91,
                1709269200
            ],
            [
                177.05,
                1709528400
            ],
            [
                179.16,
                1709614800
            ],
            [
                181.06,
                1709701200
            ],
            [
                180.57,
                1709787600
            ],
            [
                178.85,
                1709874000
            ],
            [
                179.63,
                1710129600
            ],
            [
                180.92,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5477,
        "drug_name": "EVKEEZA (evinacumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Homozygous familial hypercholesterolemia (HoFH)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-11",
        "link": "https:\/\/www.prnewswire.com\/news-releases\/fda-approves-first-in-class-evkeeza-evinacumab-dgnb-for-patients-with-ultra-rare-inherited-form-of-high-cholesterol-301227183.html",
        "note": "FDA approval announced February 11, 2021.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2418,
        "drug_name": "COSELA (trilaciclib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Second\/third-line small-cell lung cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-12",
        "link": "https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-drug-reduce-bone-marrow-suppression-caused-chemotherapy",
        "note": "FDA approval announced February 12, 2021.",
        "company_entity_id": 440,
        "company_ticker": "GTHX",
        "company_name": "G1 Therapeutics Inc.",
        "company_price": "3.3200",
        "company_change": -0.16000000000000003,
        "company_percent_change": -4.6,
        "company_optionable": 1,
        "company_number_of_shares": 52199394,
        "price_change_sparkline": [
            [
                3.95,
                1706677200
            ],
            [
                4.46,
                1706763600
            ],
            [
                4.21,
                1706850000
            ],
            [
                4.4,
                1707109200
            ],
            [
                4.7,
                1707195600
            ],
            [
                4.83,
                1707282000
            ],
            [
                4.7,
                1707368400
            ],
            [
                4.53,
                1707454800
            ],
            [
                4.48,
                1707714000
            ],
            [
                2.1,
                1707800400
            ],
            [
                2.355,
                1707886800
            ],
            [
                2.4,
                1707973200
            ],
            [
                2.38,
                1708059600
            ],
            [
                2.26,
                1708405200
            ],
            [
                2.16,
                1708491600
            ],
            [
                2.15,
                1708578000
            ],
            [
                2.22,
                1708664400
            ],
            [
                2.3,
                1708923600
            ],
            [
                2.4,
                1709010000
            ],
            [
                3.33,
                1709096400
            ],
            [
                3.32,
                1709182800
            ],
            [
                3.73,
                1709269200
            ],
            [
                3.66,
                1709528400
            ],
            [
                3.54,
                1709614800
            ],
            [
                3.53,
                1709701200
            ],
            [
                3.58,
                1709787600
            ],
            [
                3.64,
                1709874000
            ],
            [
                3.48,
                1710129600
            ],
            [
                3.32,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7505,
        "drug_name": "PANZYGA",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-12",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210212005537\/en\/",
        "note": "FDA approval announced February 12, 2021.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6184,
        "drug_name": "LIBTAYO (cemiplimab)",
        "clinical_trial_id": "NCT03409614",
        "has_trial_insight_page": 0,
        "indication": "Non-small cell lung cancer (NSCLC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-22",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3c9a01b9-6467-462e-a5de-f861ff8190ba",
        "note": "FDA approval announced February 22, 2021.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6184,
        "drug_name": "LIBTAYO (cemiplimab)",
        "clinical_trial_id": "NCT03409614",
        "has_trial_insight_page": 0,
        "indication": "Non-small cell lung cancer (NSCLC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-22",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3c9a01b9-6467-462e-a5de-f861ff8190ba",
        "note": "FDA approval announced February 22, 2021.",
        "company_entity_id": 389,
        "company_ticker": "SNY",
        "company_name": "Sanofi",
        "company_price": "48.4600",
        "company_change": 0.11,
        "company_percent_change": 0.23,
        "company_optionable": 1,
        "company_number_of_shares": 2529599938,
        "price_change_sparkline": [
            [
                49.9,
                1706677200
            ],
            [
                48.41,
                1706763600
            ],
            [
                47.23,
                1706850000
            ],
            [
                46.95,
                1707109200
            ],
            [
                47.06,
                1707195600
            ],
            [
                46.92,
                1707282000
            ],
            [
                46.56,
                1707368400
            ],
            [
                46.5,
                1707454800
            ],
            [
                46.34,
                1707714000
            ],
            [
                45.75,
                1707800400
            ],
            [
                45.8,
                1707886800
            ],
            [
                46.39,
                1707973200
            ],
            [
                46.18,
                1708059600
            ],
            [
                46.85,
                1708405200
            ],
            [
                47.92,
                1708491600
            ],
            [
                47.8,
                1708578000
            ],
            [
                48.77,
                1708664400
            ],
            [
                48.2,
                1708923600
            ],
            [
                48.21,
                1709010000
            ],
            [
                48,
                1709096400
            ],
            [
                47.85,
                1709182800
            ],
            [
                47.29,
                1709269200
            ],
            [
                47.15,
                1709528400
            ],
            [
                47.5,
                1709614800
            ],
            [
                47.68,
                1709701200
            ],
            [
                48.06,
                1709787600
            ],
            [
                48.25,
                1709874000
            ],
            [
                48.35,
                1710129600
            ],
            [
                48.46,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 1907,
        "drug_name": "AMONDYS 45 (casimersen)",
        "clinical_trial_id": "NCT02500381",
        "has_trial_insight_page": 1,
        "indication": "Duchenne muscular dystrophy",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-25",
        "link": "https:\/\/www.globenewswire.com\/news-release\/2021\/02\/25\/2182845\/0\/en\/Sarepta-Therapeutics-Announces-FDA-Approval-of-AMONDYS-45-casimersen-Injection-for-the-Treatment-of-Duchenne-Muscular-Dystrophy-DMD-in-Patients-Amenable-to-Skipping-Exon-45.html",
        "note": "FDA approval announced February 25, 2021.",
        "company_entity_id": 285,
        "company_ticker": "SRPT",
        "company_name": "Sarepta Therapeutics Inc.",
        "company_price": "122.0000",
        "company_change": 0.42,
        "company_percent_change": 0.35,
        "company_optionable": 1,
        "company_number_of_shares": 93855410,
        "price_change_sparkline": [
            [
                118.99,
                1706677200
            ],
            [
                122.83,
                1706763600
            ],
            [
                121.27,
                1706850000
            ],
            [
                125.55,
                1707109200
            ],
            [
                126.41,
                1707195600
            ],
            [
                126.05,
                1707282000
            ],
            [
                127.38,
                1707368400
            ],
            [
                126.87,
                1707454800
            ],
            [
                127.32,
                1707714000
            ],
            [
                124.19,
                1707800400
            ],
            [
                124.3,
                1707886800
            ],
            [
                124.89,
                1707973200
            ],
            [
                134.61,
                1708059600
            ],
            [
                136.14,
                1708405200
            ],
            [
                132.29,
                1708491600
            ],
            [
                134.78,
                1708578000
            ],
            [
                136.53,
                1708664400
            ],
            [
                137.65,
                1708923600
            ],
            [
                141.53,
                1709010000
            ],
            [
                137.5,
                1709096400
            ],
            [
                127.9,
                1709182800
            ],
            [
                128.67,
                1709269200
            ],
            [
                123.88,
                1709528400
            ],
            [
                122.85,
                1709614800
            ],
            [
                120.31,
                1709701200
            ],
            [
                120.78,
                1709787600
            ],
            [
                124.37,
                1709874000
            ],
            [
                121.58,
                1710129600
            ],
            [
                122,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6059,
        "drug_name": "Fosdenopterin (BBP-870\/ORGN001)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Molybdenum cofactor deficiency type A",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-02-26",
        "link": "https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=214018",
        "note": "FDA approved February 26, 2021.",
        "company_entity_id": 680,
        "company_ticker": "BBIO",
        "company_name": "BridgeBio Pharma Inc.",
        "company_price": "28.7000",
        "company_change": -0.24,
        "company_percent_change": -0.83,
        "company_optionable": 1,
        "company_number_of_shares": 175831536,
        "price_change_sparkline": [
            [
                34.29,
                1706677200
            ],
            [
                33.31,
                1706763600
            ],
            [
                33.91,
                1706850000
            ],
            [
                33.63,
                1707109200
            ],
            [
                34.02,
                1707195600
            ],
            [
                33.77,
                1707282000
            ],
            [
                32.96,
                1707368400
            ],
            [
                34.47,
                1707454800
            ],
            [
                35.65,
                1707714000
            ],
            [
                33.57,
                1707800400
            ],
            [
                34.37,
                1707886800
            ],
            [
                39.23,
                1707973200
            ],
            [
                37.21,
                1708059600
            ],
            [
                35.95,
                1708405200
            ],
            [
                34.16,
                1708491600
            ],
            [
                33.6,
                1708578000
            ],
            [
                34,
                1708664400
            ],
            [
                34.87,
                1708923600
            ],
            [
                35.73,
                1709010000
            ],
            [
                35.29,
                1709096400
            ],
            [
                34.15,
                1709182800
            ],
            [
                35.63,
                1709269200
            ],
            [
                32.355,
                1709528400
            ],
            [
                29.6,
                1709614800
            ],
            [
                29.45,
                1709701200
            ],
            [
                30,
                1709787600
            ],
            [
                28.98,
                1709874000
            ],
            [
                28.94,
                1710129600
            ],
            [
                28.7,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3051,
        "drug_name": "AZSTARYS",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "ADHD",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-03-02",
        "link": "https:\/\/investors.kempharm.com\/news-releases\/news-release-details\/kempharm-announces-fda-approval-azstarystm-serdexmethylphenidate",
        "note": "FDA approval announced March 2, 2021.",
        "company_entity_id": 2030,
        "company_ticker": "ZVRA",
        "company_name": "Zevra Therapeutics Inc.",
        "company_price": "6.2400",
        "company_change": 0.11,
        "company_percent_change": 1.79,
        "company_optionable": 1,
        "company_number_of_shares": 36218164,
        "price_change_sparkline": [
            [
                5.79,
                1706677200
            ],
            [
                5.96,
                1706763600
            ],
            [
                5.78,
                1706850000
            ],
            [
                5.77,
                1707109200
            ],
            [
                5.905,
                1707195600
            ],
            [
                5.81,
                1707282000
            ],
            [
                5.95,
                1707368400
            ],
            [
                6.15,
                1707454800
            ],
            [
                6.11,
                1707714000
            ],
            [
                5.76,
                1707800400
            ],
            [
                6.14,
                1707886800
            ],
            [
                6.68,
                1707973200
            ],
            [
                6.86,
                1708059600
            ],
            [
                6.89,
                1708405200
            ],
            [
                6.78,
                1708491600
            ],
            [
                6.8,
                1708578000
            ],
            [
                6.63,
                1708664400
            ],
            [
                6.87,
                1708923600
            ],
            [
                6.95,
                1709010000
            ],
            [
                6.86,
                1709096400
            ],
            [
                6.74,
                1709182800
            ],
            [
                7.08,
                1709269200
            ],
            [
                6.22,
                1709528400
            ],
            [
                5.91,
                1709614800
            ],
            [
                6.25,
                1709701200
            ],
            [
                6.31,
                1709787600
            ],
            [
                6.1,
                1709874000
            ],
            [
                6.13,
                1710129600
            ],
            [
                6.24,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7572,
        "drug_name": "ACTEMRA (tocilizumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Systemic sclerosis-associated interstitial lung disease (SSc-ILD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2021-03-04",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210304006148\/en\/",
        "note": "FDA approval announced March 4, 2021.",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": []
    }
]